NFGH
VIR icon

Nan Fung Group Holdings’s Vir Biotechnology VIR Stock Holding History

Nan Fung Group Holdings’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-210,563
Closed -$5.42M – 46
2022
Q1 		$5.42M Hold
210,563
– – 2.57% 10
2021
Q4 		$8.82M Buy
210,563
+50,352
+31% +$1.97M 2.61% 8
2021
Q3 		$6.97M Buy
160,211
+91,548
+133% +$3.96M 2.23% 9
2021
Q2 		$3.25M Buy
+68,663
New +$3.12M 1.01% 11

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
APF
Alaska Permanent Fund Juneau, Alaska $1.57B AUM 15.23% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

Nan Fung Group Holdings's VIR Position: Q2 2022 in Review

Nan Fung Group Holdings sold out of Vir Biotechnology (VIR) in Q2 2022, closing a stake of 210,563 shares — an estimated $5.42M sold.

Nan Fung Group Holdings first reported a position in VIR in Q2 2021 and held it in 4 quarters. The position peaked at $8.82M in Q4 2021. 211 funds tracked by Wall St. Rank hold VIR as of Q2 2022.

  • Nan Fung Group Holdings reported no remaining Vir Biotechnology position as of Q2 2022 after selling out during the quarter.
  • Nan Fung Group Holdings sold 210,563 Vir Biotechnology shares in Q2 2022, an estimated $5.42M.
  • Nan Fung Group Holdings first reported a position in Vir Biotechnology in Q2 2021 and held it in 4 quarters.
  • Nan Fung Group Holdings's Vir Biotechnology position peaked at $8.82M in Q4 2021.
  • 211 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2022.

Based on Nan Fung Group Holdings's 13F filing for Q2 2022, filed 12 Aug 2022.